מקדם חוב לטווח ארוך להון Olema Corp (OLMA)

Olema Pharmaceuticals (OLMA) specializes in combating breast cancer, leveraging the success of medical tests and drug patent protections. The business remains insulated from market volatility due to stable demand, while its dynamics depend on investments, as expressed by the value 0.01. By implementing environmental standards in its laboratories, the company reduces harmful emissions. This chart of stock price action clearly illustrates these fundamental indicators.

The implementation of sustainable green chemistry methods and the modernization of Olema Pharmaceuticals (OLMA) laboratories require significant capital expenditures, which may be financed through borrowed funds. The ratio of liabilities with a maturity of over one year to equity determines the company's degree of dependence on creditors, while financial leverage based on long-term debt allows for the timely detection of rising insolvency risks and helps avoid purchasing the asset at its peak.